JEG Tower Switches To COREnergy To Power Cebu’s Business Community

JEG Tower partners with COREnergy to power Cebu’s business community through more strategic and stable energy management.

From Credit Card Hacks To A Movement: How KasKasan Buddies Grew Into A Financial Literacy Community

KasKasan Buddies grew from credit card conversations into a two-million-member community helping Filipinos navigate financial literacy, digital safety, and smarter money decisions.

Monde Nissin Reports Record First Half Core Net Income Attributable To Shareholders Of PHP5.5 Bn, An Increase Of 16.1%

Monde Nissin reports stronger first-half earnings as revenue growth, margin gains, and disciplined cost management support its performance.

Converge Global Business Empowers Virtual Staffing Solutions With Seamless International And Domestic Connectivity

Converge Global Business partners with Virtual Staffing Solutions to power secure connectivity across Philippine and U.S. operations.

Global Coronavirus Cases Surpass 40M

The number of the COVID-19 cases in the world has surpassed 40 million on Monday.

Global Coronavirus Cases Surpass 40M

94
94

How do you feel about this story?

Express Your Reaction
Like
Love
Haha
Wow
Sad
Angry

The number of the coronavirus disease 2019 (Covid-19) cases in the world has surpassed 40 million early Monday, according to Johns Hopkins University data.

More than 1.11 million people have lost their lives around the world from Covid-19 so far.

The US still leads the world in the number of Covid-19 cases with over 8.15 million, while deaths are at almost 220,000.

In India, more than 7.55 million people contracted the virus with a death toll of over 114,600. Brazil has more than 5.22 million cases and a death toll exceeding 153,600.

China, the birthplace of Covid-19, has close to 91,000 cases with 4,739 deaths.

The UK’s Scientific Advisory Group for Emergencies said Sunday more than one coronavirus vaccine will be available at the beginning of 2021.

American pharmaceutical firm Pfizer said Friday it may know the effectiveness of its vaccine by the end of October, and it is planning to submit safety data on the final dose of the vaccine to the US Food and Drug Administration in the third week of November.

A vaccine candidate developed by the Beijing Institute of Biological Products, affiliated to the state-owned China National Pharmaceutical Group (Sinopharm), elicited antibody response in recipients, according to a study published Thursday in the Lancet Infectious Diseases journal.

Meanwhile, Russian President Vladimir Putin said Wednesday that a second coronavirus vaccine, EpiVakKorona, has been granted regulatory approval.

There are more than 170 vaccines around the world that are candidates for Covid-19 and tracked by the World Health Organization, but none has been approved for general use yet. (PNA)